SPY329.14+0.35 0.11%
DIA267.24+0.52 0.20%
IXIC10,916.44+13.64 0.13%

Prevail Therapeutics Q3 EPS $(0.62) Up From $(0.99) YoY

Prevail Therapeutics (NASDAQ:PRVL) reported quarterly losses of $(0.62) per share. This is a 37.37 percent increase over losses of $(0.99) per share from the same period last year.

Benzinga · -

Prevail Therapeutics (NASDAQ:PRVL) reported quarterly losses of $(0.62) per share. This is a 37.37 percent increase over losses of $(0.99) per share from the same period last year.